Lee C S, Buttitta L A, May N R, Kispert A, Fan C M
Department of Embryology, Carnegie Institution of Washington, Baltimore, MD 21210, USA.
Development. 2000 Jan;127(1):109-18. doi: 10.1242/dev.127.1.109.
Dorsoventral polarity of the somitic mesoderm is established by competitive signals originating from adjacent tissues. The ventrally located notochord provides the ventralizing signals to specify the sclerotome, while the dorsally located surface ectoderm and dorsal neural tube provide the dorsalizing signals to specify the dermomyotome. Noggin and SHH-N have been implicated as the ventralizing signals produced by the notochord. Members of the WNT family of proteins, on the other hand, have been implicated as the dorsalizing signals derived from the ectoderm and dorsal neural tube. When presomitic explants are confronted with cells secreting SHH-N and WNT1 simultaneously, competition to specify the sclerotome and dermomyotome domains within the naive mesoderm can be observed. Here, using these explant cultures, we provide evidence that SHH-N competes with WNT1, not only by upregulating its own receptor Ptc1, but also by upregulating Sfrp2 (Secreted frizzled-related protein 2), which encodes a potential WNT antagonist. Among the four known Sfrps, Sfrp2 is the only member expressed in the sclerotome and upregulated by SHH-N recombinant protein. We further show that SFRP2-expressing cells can reduce the dermomyotome-inducing activity of WNT1 and WNT4, but not that of WNT3a. Together, our results support the model that SHH-N at least in part employs SFRP2 to reduce WNT1/4 activity in the somitic mesoderm.
体节中胚层的背腹极性是由相邻组织产生的竞争性信号所确立的。位于腹侧的脊索提供腹侧化信号以确定生骨节,而位于背侧的表面外胚层和背侧神经管则提供背侧化信号以确定皮肌节。Noggin和SHH-N被认为是脊索产生的腹侧化信号。另一方面,WNT蛋白家族的成员被认为是源自外胚层和背侧神经管的背侧化信号。当体节形成前的外植体同时与分泌SHH-N和WNT1的细胞接触时,可以观察到在未分化的中胚层内确定生骨节和皮肌节区域的竞争。在此,利用这些外植体培养物,我们提供证据表明,SHH-N不仅通过上调其自身受体Ptc1,而且还通过上调Sfrp2(分泌型卷曲相关蛋白2)来与WNT1竞争,Sfrp2编码一种潜在的WNT拮抗剂。在四种已知的Sfrps中,Sfrp2是唯一在生骨节中表达并被SHH-N重组蛋白上调的成员。我们进一步表明,表达SFRP2的细胞可以降低WNT1和WNT4诱导皮肌节的活性,但不能降低WNT3a的活性。总之,我们的结果支持这样一种模型,即SHH-N至少部分地利用SFRP2来降低体节中胚层中WNT1/4的活性。